Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Cheezheng Tibetan Medicine to IPO on Shenzhen Exchange

publication date: Aug 12, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Cheezheng Tibetan Medicine Co. has been approved to IPO on the Shenzhen exchange. It will offer up to 41 million shares in the offering. The approval gives evidence that the IPO market in China is continuing to open for life science companies, following the almost year-long absence of any activity as worldwide financial markets imploded. Established in 1992, Cheezheng Tibetan was the first pharmaceutical company in Tibet to be granted GMP certification. The company offers products that are drawn from the practices of traditional Tibetan Medicine. More details...

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...